About
Caris Life Sciences, Inc. Common Stock (NASDAQ:CAI) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients
Apr 24 2026
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
Apr 20 2026
Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026
Apr 17 2026
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
Apr 15 2026
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
Financials
Revenue
$812.03 M
Market Cap
$5.45 B
EPS
-3.22
Translate